AT382367B - Verfahren zur herstellung von neuen azetidinverbindungen - Google Patents

Verfahren zur herstellung von neuen azetidinverbindungen

Info

Publication number
AT382367B
AT382367B AT0281283A AT281283A AT382367B AT 382367 B AT382367 B AT 382367B AT 0281283 A AT0281283 A AT 0281283A AT 281283 A AT281283 A AT 281283A AT 382367 B AT382367 B AT 382367B
Authority
AT
Austria
Prior art keywords
producing new
azetidine compounds
new azetidine
compounds
producing
Prior art date
Application number
AT0281283A
Other languages
English (en)
Other versions
ATA281283A (de
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Priority to AT0281283A priority Critical patent/AT382367B/de
Publication of ATA281283A publication Critical patent/ATA281283A/de
Application granted granted Critical
Publication of AT382367B publication Critical patent/AT382367B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
AT0281283A 1982-08-04 1983-08-03 Verfahren zur herstellung von neuen azetidinverbindungen AT382367B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0281283A AT382367B (de) 1982-08-04 1983-08-03 Verfahren zur herstellung von neuen azetidinverbindungen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40494582A 1982-08-04 1982-08-04
AT0281283A AT382367B (de) 1982-08-04 1983-08-03 Verfahren zur herstellung von neuen azetidinverbindungen

Publications (2)

Publication Number Publication Date
ATA281283A ATA281283A (de) 1986-07-15
AT382367B true AT382367B (de) 1987-02-25

Family

ID=23601669

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0281283A AT382367B (de) 1982-08-04 1983-08-03 Verfahren zur herstellung von neuen azetidinverbindungen

Country Status (33)

Country Link
US (1) US4939253A (de)
JP (1) JPS5993046A (de)
KR (1) KR900001211B1 (de)
AR (1) AR241158A1 (de)
AT (1) AT382367B (de)
AU (1) AU568086B2 (de)
BE (1) BE897466A (de)
CH (1) CH655309A5 (de)
CS (4) CS243498B2 (de)
DD (1) DD213919A5 (de)
DE (1) DE3328047A1 (de)
DK (1) DK354683A (de)
ES (1) ES524698A0 (de)
FI (1) FI832675A (de)
FR (1) FR2531427A1 (de)
GB (1) GB2125794B (de)
GR (1) GR79368B (de)
HU (1) HU191058B (de)
IE (1) IE55839B1 (de)
IL (1) IL69381A (de)
IN (1) IN160955B (de)
IT (1) IT1224129B (de)
LU (1) LU84947A1 (de)
NL (1) NL8302746A (de)
NO (1) NO832801L (de)
NZ (1) NZ205111A (de)
PL (3) PL257441A1 (de)
PT (1) PT77155B (de)
RO (1) RO86511B (de)
SE (1) SE8304256L (de)
SU (1) SU1329617A3 (de)
YU (1) YU43324B (de)
ZA (1) ZA835470B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs
US4548747A (en) * 1983-05-02 1985-10-22 E. R. Squibb & Sons, Inc. 3-Acylamino-1-sulfonylaminocarbonylmethoxy-2-azetidinones
ATE39356T1 (de) * 1983-05-31 1989-01-15 Squibb & Sons Inc (((3-acylamino-2-oxo-1-azetidinyl)oxy>methyl>phosphins|ure.
US4534896A (en) * 1983-06-13 1985-08-13 E. R. Squibb & Sons, Inc. 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)
US4548751A (en) * 1983-08-03 1985-10-22 E. R. Squibb & Sons, Inc. (2-Oxo-1-azetidinyloxy)-2-propenoic acid
AU581180B2 (en) * 1983-08-26 1989-02-16 E.R. Squibb & Sons, Inc. 1-(1h-tetrazol-5-ylalkoxy)-2-azetidinones
CA1243679A (en) * 1983-09-14 1988-10-25 Henner Straub 3-ACYLAMINO-2-OXO-1-AZETIDINYL-.beta.-OXYPROPIONATES
WO1985004876A1 (en) * 1984-04-24 1985-11-07 Takeda Chemical Industries, Ltd. 2-azetidinone derivatives and process for their preparation
EP0135194A1 (de) * 1983-09-16 1985-03-27 Takeda Chemical Industries, Ltd. Azetidinone und ihre Herstellung
US4559335A (en) * 1983-10-03 1985-12-17 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethyloxy (or thio) carbonyl-2-azetidinones
US4576749A (en) * 1983-10-03 1986-03-18 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
US4551277A (en) * 1983-11-09 1985-11-05 E. R. Squibb & Sons, Inc. 4-(3-Acylamino-2-oxo-1-azetidinyl)-4-oxo-2-butenoic acid
US4581170A (en) * 1984-08-03 1986-04-08 E. R. Squibb & Sons, Inc. N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
EG18314A (en) * 1985-09-26 1993-02-28 Squibb & Sons Inc Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
US5112968A (en) * 1989-07-28 1992-05-12 E. R. Squibb & Sons, Inc. Monobactam hydrazide derivatives
JP2008520686A (ja) * 2004-11-17 2008-06-19 スミスクライン・ビーチャム・コーポレイション 新規な抗菌化合物の使用
CA2629570C (en) * 2005-12-07 2012-11-27 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
WO2014164526A1 (en) * 2013-03-13 2014-10-09 Rempex Pharmaceuticals, Inc. Oxamazin antibiotics
US20140275007A1 (en) * 2013-03-14 2014-09-18 Rempex Pharmaceuticals, Inc. Oxamazin antibiotics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ205240A (en) * 1980-02-07 1984-07-31 Squibb & Sons Inc Sulphonamide derivatives,being starting materials for producing beta-lactams
EP0048953B1 (de) * 1980-09-29 1988-03-09 E.R. Squibb & Sons, Inc. Beta-Lactam-Antibiotika
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs

Also Published As

Publication number Publication date
ES8502114A1 (es) 1984-12-16
NO832801L (no) 1984-02-06
SE8304256D0 (sv) 1983-08-03
SE8304256L (sv) 1984-02-05
LU84947A1 (fr) 1984-03-23
KR900001211B1 (ko) 1990-02-28
GB2125794A (en) 1984-03-14
PT77155B (en) 1986-01-28
CH655309A5 (fr) 1986-04-15
IN160955B (de) 1987-08-22
GB2125794B (en) 1985-12-18
IE831830L (en) 1984-02-04
AR241158A1 (es) 1991-12-30
IE55839B1 (en) 1991-01-30
FR2531427A1 (fr) 1984-02-10
DK354683A (da) 1984-02-05
CS243498B2 (en) 1986-06-12
BE897466A (fr) 1984-02-06
IL69381A0 (en) 1983-11-30
AR241158A2 (es) 1991-12-30
AU568086B2 (en) 1987-12-17
NZ205111A (en) 1986-06-11
RO86511A (ro) 1985-03-15
CS26783A2 (en) 1985-08-31
PL257440A1 (en) 1986-10-07
ES524698A0 (es) 1984-12-16
CS243474B2 (en) 1986-06-12
US4939253A (en) 1990-07-03
AU1755683A (en) 1984-02-09
PT77155A (en) 1983-09-01
YU43324B (en) 1989-06-30
SU1329617A3 (ru) 1987-08-07
CS243499B2 (en) 1986-06-12
DD213919A5 (de) 1984-09-26
DE3328047A1 (de) 1984-02-09
CS26785A2 (en) 1985-08-15
HU191058B (en) 1986-12-28
GB8320497D0 (en) 1983-09-01
PL243308A1 (en) 1985-12-17
CS575983A2 (en) 1985-08-15
YU162783A (en) 1986-02-28
FR2531427B1 (de) 1985-04-19
IT1224129B (it) 1990-09-26
IT8322430A0 (it) 1983-08-04
PL257441A1 (en) 1986-10-07
KR840005814A (ko) 1984-11-19
JPS5993046A (ja) 1984-05-29
ZA835470B (en) 1984-04-25
ATA281283A (de) 1986-07-15
GR79368B (de) 1984-10-22
RO86511B (ro) 1985-03-31
IL69381A (en) 1987-07-31
CS26885A2 (en) 1985-08-31
DK354683D0 (da) 1983-08-03
FI832675A0 (fi) 1983-07-22
NL8302746A (nl) 1984-03-01
FI832675A (fi) 1984-02-05

Similar Documents

Publication Publication Date Title
AT383129B (de) Verfahren zur herstellung von neuen cephalosporinverbindungen
AT382367B (de) Verfahren zur herstellung von neuen azetidinverbindungen
ATA206483A (de) Verfahren zur herstellung von neuen mitosanderivaten
ATA125383A (de) Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen
AT382638B (de) Verfahren zur herstellung von neuen trehaloselipiden
AT382155B (de) Verfahren zur herstellung von neuen cephalosporinverbindungen
AT382620B (de) Verfahren zur herstellung von neuen carbapenem-derivaten
AT387019B (de) Verfahren zur herstellung von neuen mitomycinverbindungen
AT382621B (de) Verfahren zur herstellung von neuen carbapenem-derivaten
AT375943B (de) Verfahren zur herstellung von neuen mitosanverbindungen
AT386828B (de) Verfahren zur herstellung von neuen acylaminomitosanen
AT385035B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT376222B (de) Verfahren zur herstellung von neuen azinorifamycinverbindungen
ATA279784A (de) Verfahren zur herstellung von neuen 2-aminomethyl-2-penem-verbindungen
AT385509B (de) Verfahren zur herstellung von neuen mitosanverbindungen
AT387385B (de) Verfahren zur herstellung von neuen substituierten 1-pyridyloxy-3-indolylalkylamino-2-propanolen
ATA139685A (de) Verfahren zur herstellung von neuen cephalosporinverbindungen
ATA228183A (de) Verfahren zur herstellung von neuen polyprenylverbindungen
ATA91083A (de) Verfahren zur herstellung von neuen dicarbamaten
AT378776B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
AT377980B (de) Verfahren zur herstellung von neuen diastereomeren
AT382378B (de) Verfahren zur herstellung von neuen cephemverbindungen
ATA368685A (de) Verfahren zur herstellung von neuen cephemverbindungen
AT388163B (de) Verfahren zur herstellung von neuen cephalosporinverbindungen
ATA76786A (de) Verfahren zur herstellung von neuen cephalosporinverbindungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee